Minapharm Pharmaceuticals S.A.E. (MIPH.CA)

Also known as:  MINAPHARM
Data delayed by 15 minutes
86.50 EGP 0.000.00%
As of 21 JAN 2021 12:05 GMT|Egypt SE

MINAPHARM Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
6.243%
P/E (Last 12 Month)
3.92
Upside
-
Target Price (Mean)
-
52Wk
80.3 03 JAN
88.3 20 JAN

Open
84.21 EGP
Previous Close
86.50 EGP
Turnover
239.59K EGP
EPS
22.068 EGP
Volume
2,772
Transactions
14
Market Cap
1.06B EGP
IPO Date
11-Jan-2004
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Minapharm Pharmaceuticals S.A.E.Last updated on: 22 August 2019

Business Summary
Production of licensed and generic pharmaceuticals, vaccines, veterinary products, drug delivery systems, cosmetics and skin care supplies.
Country of Incorporation
Ownership Type
Established In
1986
Primary Sector
Number of Employees
-
Stock Listing
IDStock TypeCurrencyExchangeSymbol
MIPH.CASEOrdinaryEGPEgypt SEMIPH

Contact details

Primary address
Building: Building 6C
Street: El Bardissi Street, 2T Taksim Asmaa Fahmy Street
Floor: 2nd Floor
Country: Egypt
City: Heliopolis
CONTACT
Related links
www.probiogen.de
Region
Cairo

Minapharm profit skyrockets

Minapharm Pharmaceuticals (Minapharm) reported a 184% Year on Year increase in its consolidated net profit in the first nine months

Arab Finance - 29 Nov 2020
More
All Health Care News

Bitcoin heads for worst weekly loss in months

The world's most popular cryptocurrency fell more than 5% to an almost three-week low of $28,800 early in the Asia session, before steadying near $32,000

Reuters News - 11 hours ago
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Dr Wafiq Saad Al Bardissi
Managing Director
Mr Albert Sami Barsoum
Investor Relations Manager

Board Members

Dr Wafiq Saad Al Bardissi
Chairman
Dr Amro Sobhi Mohammed Sobhy Hamza El-Shabrawishy
Vice Chairman
Dr Anwar Nasser Mikhael
Director
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
MEDICAL PACK0.715 EGP-2.189
CLEOPATRA HOSP4.820 EGP-1.23
EGYPT INTL PHRM41.490 EGP1.047
CAIRO PHARMAC.36.050 EGP0.111
ALX. PHARMACEUT.136.000 EGP-0.015
More

Thursday Outlook: Asian stocks at record highs; dollar on back foot

Thursday Outlook: Asian stocks at record highs; dollar on back foot

Oil slips; gold off two-week high on profit booking

More

Most Viewed Stocks

Stock Screener

More